Patent ID: 8637012

Claim:
A method of treating a cancer disease characterized by expression or abnormal expression of a tumor-associated antigen, comprising: administering to a patient having said cancer disease a pharmaceutical composition including an antibody or an antigen binding fragment thereof that is capable of specifically binding to a tumor-associated antigen that is expressed or abnormally expressed on a cell, said tumor-associated antigen being selected from the group consisting of: (a) a tumor-associated antigen comprising the amino acid sequence of SEQ ID NO: 16; and (b) a tumor-associated antigen encoded by a nucleic acid comprising SEQ ID NO: 7, wherein said antibody binds to an epitope within the amino acid sequence according to SEQ ID NO: 112; and wherein the cancer disease is selected from the group consisting of esophageal cancer, stomach cancer, gastric carcinoma, liver cancer, and ear, nose and throat (ENT) cancer.